Effect of Tirzepatide on Progression of Coronary Atherosclerosis Using MDCT

NCT05708859 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

120

Enrollment

OTHER

Sponsor class

Conditions

Type II Diabetes
Atherosclerosis

Interventions

DRUG: Tirzepatide
DRUG: Placebo

Sponsor

Matthew J. Budoff

Collaborators

[object Object]